Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 1, 2006, Pages

  Campbell, William B ^a   Holmes, Blythe B ^a   Falck, John R ^b   Capdevila, Jorge H ^c   Gauthier, Kathryn M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Arachidonic acid; Endothelium derived hyperpolarizing factor; Vascular relaxation

Indexed keywords

14,15 DIHYDROXYEICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 17 OCTADECYNOIC ACID; ARACHIDONIC ACID; BETA GALACTOSIDASE; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; METHACHOLINE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG; 14,15 EPOXY 5,8,11 EICOSATRIENOIC ACID; 14,15-EPOXY-5,8,11-EICOSATRIENOIC ACID; ARACHIDONATE EPOXYGENASE; DIHOMO GAMMA LINOLENIC ACID; DRUG DERIVATIVE; METHACHOLINE CHLORIDE; OXYGENASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BACILLUS MEGATERIUM; CONTROLLED STUDY; CORONARY ARTERY; CYTOMEGALOVIRUS; ENZYME ACTIVITY; ESCHERICHIA COLI; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREACTIVITY; INCUBATION TIME; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; VIRUS EXPRESSION; ANIMAL; BIOSYNTHESIS; CATTLE; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MUSCLE TONE; PHYSIOLOGY; STEREOISOMERISM; VASCULAR SMOOTH MUSCLE;

8,11,14-EICOSATRIENOIC ACID; ADENOVIRIDAE; ANIMALS; BACILLUS MEGATERIUM; BETA-GALACTOSIDASE; CATTLE; CORONARY VESSELS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOMEGALOVIRUS; METHACHOLINE CHLORIDE; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; OXYGENASES; POTASSIUM CHANNELS; STEREOISOMERISM; TRANSDUCTION, GENETIC;

EID: 33644815636     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00516.2005     Document Type: Article

References (37)

1. Ayajiki K, Ozaki M, Shiomo M, Okamura T, and Toda N. Comparison of endothelium-dependent relaxation in carotid arteries from Japanese white and watanabe heritable hyperlipidemic rabbits. J Cardiovasc Pharmacol 36: 622-630, 2000.
2. Ca channels. Am J Physiol Heart Circ Physiol 282: H1656-H1664, 2002.
3. Campbell WB, Gebremehdin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived relaxing factors. Circ Res 78: 415-423, 1996.
4. Capdevila JH and Falck JR. Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. Prostagland Lipid Mediat 68-69: 325-344, 2002.
5. Chen JK, Wang DW, Falck JR, Capdevila J, and Harris RC. Transfection of an active cytochrome P450 arachidonic acid epoxygenases indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J Biol Chem 274: 4764-4769, 1999.
6. Falck JR, Krishna UM, Reddy YK, Kumar PS, Reddy KM, Hittner SB, Deeter C, Sharma KK, Gauthier KM, and Campbell WB. Comparison of the vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. Am J Physiol Heart Circ Physiol 284: H337-H349, 2003.
7. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
8. Fleming I. Cytochrome P450 and vascular homeostasis. Circ Res 89: 753-762, 2001.
9. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, and Fujishima M. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res 70: 660-669, 1992.
10. Fukao M, Hattori Y, Kanno M, Sakuma I, and Kitabatake A. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 121: 1383-1391, 1997.
11. Ca channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Mol Pharmacol 59: 16-23, 2001.
12. Fulton D, McGiff JC, and Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol 107: 722-725, 1992.
13. Gauthier KM, Edwards EM, Falck JR, Reddy DS, and Campbell WB. 14,15-Epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries. Hypertension 45: 666-671, 2005.
14. Gauthier KM, Falck JR, Reddy LM, and Campbell WB. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol Res 49: 515-524, 2004.
15. Gauthier KM, Liu C, Popovic A, Albarwani S, and Rusch NJ. Freshly isolated bovine coronary endothelial cells do not express the BKCa channel gene. J Physiol 545: 829-836, 2002.
16. 450 metabolite. J Vasc Res 35: 274-284, 1998.
17. Graham-Lorence S, Truan G, Peterson JA, Falck JR, Wei S, Helvig C, and Capdevila JH. An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. J Biol Chem 272: 1127-1135, 1997.
18. Hecker M, Bara AT, Bauersachs J, and Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 481: 407-414, 1994.
19. Hein TW, Liao JC, and Kuo L. oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol 278: H175-H183, 2000.
20. Katakam PV, Hoenig M, Ujhelyi MR, and Miller AW. Cytochrome P450 activity and endothelial dysfunction in insulin resistance. J Vasc Res 37: 426-434, 2000.
21. Katoh T, Takahashi K, Capdevila J, Karara A, Falck JR, Jacobson HR, and Badr KF. Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 261: F578-F586, 1991.
22. Krotz F, Riexinger T, Buerkle MA, Nithipatikom K, Gloe T, Sohn HY, Campbell WB, and Pohl U. Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. Arterioscler Thromb Vasc Biol 24: 595-600. 2004.
23. Lauterbach B, Barbosa-Sicard E, Wang MH, Honeck H, Kargel E, Theuer J, Schwartzman ML, Haller H, Luft FC, Gollasch M, and Schunck WH. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 39: 609-613, 2002.
24. Li PL and Campbell WB. Epoxyeicosatrienoic acids activate potassium channels in coronary smooth muscle through guanine nucleotide binding protein. Circ Res 80: 877-884, 1997.
25. Li PL, Chen CL, Bortell R, and Campbell WB. 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. Circ Res 85: 349-356, 1999.
26. Narhi LO and Fulco AJ. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 261: 7160-7169, 1986.
27. Nithipatikom K, Grall AJ, Holmes BB, Harder DR, Falck JR, and Campbell WB. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem 298: 327-336, 2001.
28. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, and Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenasederived eicosanoids. Science 285: 1276-1279, 1999.
29. Node K, Ruan XL, Dai J, Yang SX, Graham L, Zeldin DC, and Liao JK. Activation of G alpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276: 15983-15989, 2001.
30. Pinto A, Abraham NG, and Mullane KM. Arachidonic acid-induced endothelial-dependent relaxation of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway. J Pharmacol Exp Ther 240: 856-863, 1987.
31. Popp R, Bauersachs J, Hecker M, Fleming I, and Busse R. A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol 497: 699-709, 1996.
32. Pratt PF, Li P, Hillard CJ, Kurian J, and Campbell WB. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol 280: H1113-H1121, 2001.
33. Rosolowsky M and Campbell WB. Synthesis of hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta 1299: 267-277, 1996.
34. Spiecker M and Liao JK. Vascular protective effects of cytochrome P450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 433: 413-420, 2005.
35. Wen LP and Fulco AJ. Cloning of the gene encoding a catalytically self-sufficient cytochrome P-450 fatty acid monooxygenase induced by barbiturates in Bacillus megaterium and its functional expression and regulation in heterologous (Escherichia coli) and homologous (Bacillus megaterium) hosts. J Biol Chem 262: 6676-6682, 1987.
36. Ca channels. Am J Physiol Heart Circ Physiol 280: H2430-H2440, 2001.
37. +-channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.